SCHEMBL21889229

SCHEMBL21889229

CC(N)C(=S)N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.50
▸ DPP7 Q9UHL4 2/20 0.50
▸ CA12 O43570 2/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ MGLL Q99685 5/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ PDK1 Q15118 2/20 0.45
▸ PDK2 Q15119 2/20 0.45
▸ PDK3 Q15120 2/20 0.45
▸ PHGDH O43175 2/20 0.45
▸ FAAH O00519 1/20 0.45
▸ ALDH2 P05091 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ MAPT P10636 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ DPP8 Q6V1X1 1/20 0.37
▸ DPP9 Q86TI2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10458916 0.82 CA12 (0.50) CA12CA1CA2CA9MGLL
SCHEMBL12343871 0.79 DPP4 (0.55) DPP4DPP7CA12CA1CA2
SCHEMBL5436113 0.74 SMN1; SMN2 (0.50) CA12CA1CA9ALDH1A1SMN1; SMN2
SCHEMBL6165804 0.74 SMN1; SMN2 (0.50) CA12CA1CA9ALDH1A1SMN1; SMN2
SCHEMBL14396537 0.74 SMN1; SMN2 (0.50) CA12CA1CA9ALDH1A1SMN1; SMN2
SCHEMBL24322495 0.72 SMN1; SMN2 (0.54) CA12CA1CA9ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL29646329 0.72 SMN1; SMN2 (0.48) CA12CA1CA9ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL318914 0.72 SMN1; SMN2 (0.48) CA12CA1CA9ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL318913 0.72 SMN1; SMN2 (0.48) CA12CA1CA9ALDH1A1SMN1; SMN2
SCHEMBL1986557 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3626699-B1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2023-07-12 — — EP disclosed
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 — — US disclosed
US-11001563-B2 SSAO inhibitor SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-05-11 — — US disclosed
US-20200115352-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO., LTD. 2020-04-16 — — US disclosed
EP-3626699-A1 SSAO INHIBITOR Shandong Danhong Pharmaceutical Co., Ltd. (CN) 2020-03-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001563-B2 SSAO inhibitor SSB, ASAH2, AOX1 DPP4 633/4885DPP7 801/4885CA12 3166/4885
US-20210198220-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 DPP4 633/4885DPP7 801/4885CA12 3166/4885
US-20200115352-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 DPP4 633/4885DPP7 801/4885CA12 3166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback